IRE After Targeted Immunotherapy in HCC With Portal Vein Tumor Thrombus
IRE After Targeted Immunotherapy in HCC With Portal Vein Tumor Thrombus
Recruiting · NCT07799922 · Registry updated 2026-09-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| IRE After Targeted Immunotherapy in HCC With Portal Vein Tumor Thrombus | IRE | Recruiting | Not applicable | 2026-09-02 | NCT07799922 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Tianjin Medical University Cancer Institute and Hospital | 287 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Tianjin Cancer Hospital Airport Hospital | Tianjin | China | 18 |